Clinical Trial Update: A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase II study of CP-4055 as second-line therapy in patients with advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CP-4055

Snippet

Sponsor: Clavis Pharma | Conditions: Advanced Colorectal Cancer, Colorectal Cancer | Phase 2 | Status: COMPLETED